DuPont director granted 4,030 common shares

BREEN EDWARD D reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 05/28/2026 - 04:53 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

BREEN EDWARD D reported acquisition or exercise transactions in this Form 4 filing.

DuPont de Nemours, Inc. director Edward D. Breen received an equity grant of 4,030 shares of Common Stock on May 21, 2026. The shares were awarded at a stated price of $0.0000 per share, reflecting a compensation-related grant rather than a market purchase.

Following this award, Breen directly holds 278,007.876 shares of DuPont common stock. This filing records a routine stock award to a board member, not an open-market transaction.

Insider Trade Summary

Grant/Award: 4,030 shares

Grant/Award 1 txn

Insider BREEN EDWARD D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,030	$0.00	$0.00

Holdings After Transaction: Common Stock — 278,007.876 shares (Direct)

Holdings Before and After: Common Stock, 273,977.876 to 278,007.876 shares (Direct)

Key Figures

Shares granted: 4,030 shares Grant price per share: $0.0000 per share Total shares after transaction: 278,007.876 shares +1 more

4 metrics

Shares granted 4,030 shares Equity award on May 21, 2026

Grant price per share $0.0000 per share Stated value for compensation grant

Total shares after transaction 278,007.876 shares Direct holdings following grant

Acquisition transactions in filing 1 transaction Form 4 summary acquireCount

Key Terms

Grant, award, or other acquisition, Common Stock, Form 4

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Common Stock financial

"security_title: "Common Stock" for the reported transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4): structure describing the transaction"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did DuPont (DD) director Edward D. Breen report in this Form 4?

Edward D. Breen reported receiving a grant of 4,030 DuPont common shares. The award was recorded at a price of $0.0000 per share, indicating a compensation-related stock grant rather than an open-market purchase or sale.

How many DuPont (DD) shares does Edward D. Breen hold after this transaction?

After the grant, Edward D. Breen directly holds 278,007.876 DuPont common shares. This total reflects his position following the 4,030-share award reported in the Form 4 insider transaction filing for May 21, 2026.

Was Edward D. Breen’s DuPont (DD) Form 4 transaction a buy or a sell?

The transaction was an acquisition via grant, not a market buy or sell. The Form 4 uses code “A” for a grant, award, or other acquisition, and the stated price of $0.0000 per share confirms it as a compensation-related share award.

What type of security did Edward D. Breen receive from DuPont (DD)?

Edward D. Breen received 4,030 shares of DuPont’s Common Stock. The filing classifies the transaction as a non-derivative equity award, meaning it involves actual shares rather than options, warrants, or other derivative securities.

Does this DuPont (DD) Form 4 show any stock sales by Edward D. Breen?

No stock sales are reported in this Form 4. The insider data show one acquisition transaction coded “A” for grant or award, with no sell transactions and a net buy-sell share direction described as neutral in the summary data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BREEN EDWARD D

(Last) (First) (Middle)

CHESTNUT RUN PLAZA 730

974 CENTRE ROAD

(Street)

WILMINGTON DELAWARE 19805

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DuPont de Nemours, Inc. [ DD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/21/2026		A		4,030	A	$0	278,007.876	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Paige Fleming by Power of Attorney	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)